You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 241 No. 16, April 20, 1979 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (32)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cryoprecipitate as a Reliable Source of Fibrinogen Replacement

Paul M. Ness, MD; Herbert A. Perkins, MD

JAMA. 1979;241(16):1690-1691.


Abstract

The recent withdrawal of commercial fibrinogen from the market makes alternate sources most important. Although it has been previously reported that single-donor cryoprecipitate contains appreciable amounts of fibrinogen, most clinicians need to be reminded of the reliability of cryoprecipitate for replacement of both fibrinogen and factor VIII. We assayed fibrinogen from 88 bags of cryoprecipitate prepared by five different blood banks in California and Oregon; we found that the average bag of cryoprecipitate contains at least 250 mg of fibrinogen depending on the volume of plasma processed. Cryoprecipitate was found to be a poor source of factors II, V, IX, X, XI, and XII.

(JAMA 241:1690-1691, 1979)



Author Affiliations

From the Irwin Memorial Blood Bank of the San Francisco Medical Society, San Francisco.


Footnotes

Reprint requests to Irwin Memorial Blood Bank, 270 Masonic Ave, San Francisco, CA 94118 (Dr Ness).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Fibrin Sealant as a Hemostatic Agent in Vascular Surgery
Jackson
PERSPECT VASC SURG ENDOVASC THER 2000;13:85-94.
ABSTRACT  

Efficacy of a Dry Fibrin Sealant Dressing for Hemorrhage Control After Ballistic Injury
Holcomb et al.
Arch Surg 1998;133:32-35.
ABSTRACT | FULL TEXT  

CryoSealTM System, a New Device for Generating Cryoprecipitate from Plasma
Gosselin et al.
Clin. Chem. 1997;43:1782-1783.
FULL TEXT  

Practice Parameter for the Use of Fresh-Frozen Plasma, Cryoprecipitate, and Platelets
Fresh-Frozen Plasma, Cryoprecipitate, and Platelet et al.
JAMA 1994;271:777-781.
ABSTRACT  

Bleeding during Thrombolytic Therapy for Acute Myocardial Infarction: Mechanisms and Management
Sane et al.
ANN INTERN MED 1989;111:1010-1022.
ABSTRACT  

Prophylactic Cryoprecipitate in Congenital Afibrinogenemia
Rodriguez et al.
CLIN PEDIATR 1988;27:543-545.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.